The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Mirador Capital Partners LP

Mirador Capital Partners LP lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.7% during the 3rd quarter, HoldingsChannel reports. The firm owned 13,811 shares of the medical device company’s stock after selling 996 shares during the period. Mirador Capital Partners LP’s holdings in Cooper Companies were worth $1,524,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Quantbot Technologies LP acquired a new position in Cooper Companies during the first quarter worth $2,211,000. Whittier Trust Co. grew its holdings in shares of Cooper Companies by 298.9% in the first quarter. Whittier Trust Co. now owns 11,940 shares of the medical device company’s stock valued at $1,211,000 after purchasing an additional 8,947 shares during the period. Envestnet Portfolio Solutions Inc. grew its holdings in shares of Cooper Companies by 43.1% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock valued at $3,076,000 after purchasing an additional 10,616 shares during the period. Gulf International Bank UK Ltd increased its position in Cooper Companies by 300.0% during the first quarter. Gulf International Bank UK Ltd now owns 17,148 shares of the medical device company’s stock worth $1,739,000 after purchasing an additional 12,861 shares during the last quarter. Finally, Axxcess Wealth Management LLC raised its stake in Cooper Companies by 298.4% during the first quarter. Axxcess Wealth Management LLC now owns 8,211 shares of the medical device company’s stock worth $833,000 after purchasing an additional 6,150 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 1.0 %

Cooper Companies stock traded down $1.05 during mid-day trading on Friday, reaching $105.92. 1,047,380 shares of the company’s stock were exchanged, compared to its average volume of 1,122,511. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $112.38. The company has a market cap of $21.09 billion, a P/E ratio of 62.31, a P/E/G ratio of 2.63 and a beta of 0.98. The company has a fifty day moving average of $101.43 and a 200-day moving average of $96.03.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.05. The business had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period last year, the firm earned $0.84 earnings per share. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Insider Buying and Selling at Cooper Companies

In related news, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now owns 44,696 shares in the company, valued at $4,714,534.08. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the sale, the chief operating officer now owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock valued at $27,637,427 in the last quarter. Corporate insiders own 2.00% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on COO shares. Wells Fargo & Company raised their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Piper Sandler lifted their target price on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Stifel Nicolaus reiterated a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Finally, Morgan Stanley boosted their price objective on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a report on Tuesday, September 10th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $115.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.